Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 818 of 6351
-
Smart insulin pump beats daily shots in diabetes trial
Disease control CompletedThis study is a randomized, controlled trial to evaluate the efficacy and safety of the Omnipod® 5 System with the FreeStyle Libre 2 continuous glucose monitor compared to Multiple Daily Injections (MDI) along with the FreeStyle Libre 2 continuous glucose monitor in children and …
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a common antibiotic help fight colorectal cancer?
Disease control Recruiting nowThe proposed proof-of concept trial aims at determining the effectiveness of metronidazole in decreasing the Fusobacterium nucleatum load in tissues and possibly on its detrimental effects on tumor cells and tumor microenvironment.
Phase 2 • Sponsor: Oncology Institute of Southern Switzerland • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a new antibiotic combo tame tough UTIs in kids?
Disease control Recruiting nowThis phase 2 study is part of regulatory commitments in the United States (PSP) and Europe (PIP) to evaluate cefepime-enmetazobactam in paediatric participants with cUTI to support extension of the indication for cefepime-enmetazobactam to children with cUTI.
Phase 2 • Sponsor: Orchid Pharma Europe GmbH • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Could a plasma protein cut deaths in severe pneumonia?
Disease control Recruiting nowThe main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus SoC in hospitalized subjects with sCAP on invasive mechanical ventilation (IMV). Other objectives are to determine detail…
Phase 3 • Sponsor: Biotest • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can exercise boost fitness and breathing in severe mental illness?
Symptom relief CompletedPeople with severe mental disorder, such as schizophrenia, bipolar disorder or major depression, tend to have poorer physical health and a shorter life expectancy than the general population. Exercise can help, but it is often difficult to keep up over time. In this study, adult…
Sponsor: Universidad Pablo de Olavide • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Engineered immune cells take aim at rare bone and soft tissue cancers
Disease control OngoingTo find a recommended dose of attIL2-T cell therapy that can be given to patients with soft tissue or bone sarcomas and to see if it can help to control the disease.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Brain fog after COVID: can a mental workout restore focus?
Symptom relief OngoingPost-COVID-19 condition is frequently comprised of persistent cognitive sequela, including deficits in attention and executive functions (EFs). Goal Management Training (GMT) is a cognitive rehabilitation (CR) intervention for improving attention and EFs that has received empiric…
Sponsor: Lovisenberg Diakonale Hospital • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New hope for advanced breast cancer: drug combo targets resistant tumors
Disease control Recruiting nowThis study evaluated the safety and efficacy of SPH4336 in combination with endocrine therapy in the treatment of locally advanced or metastatic breast cancer that progressed on CDK4/6 inhibitor combined with endocrine therapy.
Phase 2/3 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Gene therapy shot could end frequent eye injections for wet AMD
Disease control OngoingThis study will evaluate the safety, tolerability, and preliminary efficacy of NG101 AAV gene therapy administered by subretinal injections into a single selected eye as a single selected dose for patients with wet age-related macular degeneration (wAMD).
Phase 1/2 • Sponsor: Elisigen, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a ZAP of radiation before standard care beat back metastatic kidney cancer?
Disease control OngoingThis phase III trial compares the effect of stero-ablative radiotherapy (SAbR) followed by standard of care systemic therapy, to standard of care systemic therapy alone, in patients with kidney cancer that has spread from where it first started (primary site) to a limited (2-5) n…
Phase 3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Balloon or stent? major trial tests safer option for clogged heart arteries
Disease control OngoingProspective, randomised, open-label, international multicenter trial to evaluate the safety and efficacy of drug-coated balloon (DCB) treatment compared to drug-eluting stenting (DES) in patients with large coronary artery disease.
Sponsor: B. Braun Medical Industries Sdn. Bhd. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Lab-Made blood vessel could free dialysis patients from catheters
Disease control OngoingThe goal of this clinical trial is to compare the number of catheter-free days (CFD) and the rate and severity of any dialysis access-related infections between the ATEV and AVF groups over 12 months in patients with end-stage renal disease (ESRD) needing hemodialysis (HD). Part…
Phase 3 • Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could cannabis replace opioids for chronic pain?
Disease control CompletedThe goal of this observational study is to learn how medical cannabis (MC) affects pain and the use of opioid pain medications. Participants who have chronic pain and use prescribed opioid pain medication will opt-in to using MC or not for the 3-month study. Participants who are …
Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can 'Zombie Cell' drugs strengthen aging bones?
Disease control OngoingThis randomised clinical trial aims to study osteoporosis as a disease of accelerated skeletal aging caused by the accumulation of senescent cells within the skeleton and investigate the effects and safety of senolytics and antioxidant therapy on bone.
Phase 2 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo aims to boost bladder cancer remission before surgery
Disease control CompletedThis is a multi-center, stratified and single-blinded Phase 2 trial of neoadjuvant immunotherapy in combination with the anti-GDF15 antibody visugromab (CTL-002) for the treatment of participants with MIBC set to undergo radical Cystectomy (RC)/Re-TURBT who cannot receive or refu…
Phase 2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can tracking a precancerous condition slash myeloma diagnosis delays?
Knowledge-focused Recruiting nowMultiple Myeloma (MM) is a rare blood cancer affecting over 5000 people a year in the UK. All cases of myeloma start with a condition called monoclonal gammopathy of undetermined significance (MGUS). MGUS occurs in approximately 3.2% of people aged 50 and over. Only a small propo…
Sponsor: Oxford University Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can a drug calm long COVID's lung inflammation? new trial aims to find out
Disease control Recruiting nowThe PRECISION is a proof-of-concept, phase II randomized clinical trial aiming to evaluate the efficacy and safety of anakinra in patients with Post-Acute COVID Syndrome (PACS) of the pro-inflammatory respiratory phenotype. Improvement is measured by a composite endpoint, namely,…
Phase 2/3 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New mRNA vaccine aims to tame genital herpes recurrences
Disease control CompletedThe purpose of this study is to generate safety and immunogenicity data and establish a proof-of-concept of clinical benefit of the mRNA-1608 vaccine candidate.
Phase 1/2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy shows promise in brain cancer trial
Disease control CompletedThis is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients with newly diagnosed glioblastoma receiving concurrent radiation and temozolomide.
Phase 1/2 • Sponsor: Cantex Pharmaceuticals • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a simple blood test and PET scan replace painful bone marrow biopsies for myelofibrosis patients?
Diagnosis Recruiting nowChronic "Philadelphia-negative" myeloproliferative syndromes are chronic blood disorders. They include essential thrombocythemia, polycythemia vera, and myelofibrosis. Myelofibrosis may arise de novo ("primary myelofibrosis") or represent the evolution of essential thrombocythemi…
Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC